Company Overview
- Headquarters
- 171 Oyster Point Blvd, Suite 500, South San Francisco CA
- Website
- tenayatherapeutics.com
- Employees
- 50
- Founded in
- 2016
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$50B
Who is Tenaya Therapeutics
Tenaya Therapeutics is a clinical stage biotechnology company headquartered in South San Francisco, California. Founded in 2016, the company was established by prominent cardiovascular scientists from the David J. Gladstone Institutes and the University of Texas Southwestern Medical Center. Employing 50 individuals, Tenaya Therapeutics has generated $50 million in revenue. The company is dedicated to researching, designing, developing, and delivering curative therapies that directly address the root causes of heart disease. Tenaya Therapeutics' focus is on creating disease-modifying therapies for patients suffering from both rare and common heart conditions. Tenaya Therapeutics utilizes proprietary platforms and internal capabilities to develop targeted therapies for specific patient groups. Their goal is to reshape the treatment landscape for heart disease and ultimately improve the lives of millions affected by this debilitating condition. For more information, please visit Tenaya Therapeutics' website at tenayatherapeutics.com.
Company Leadership
Tenaya Therapeutics Industry Tags
Companies Similar to Tenaya Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Tenaya Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | Cambridge, MA | |||
| 50M | 59 | Foster City, CA | ||
| 50M | 74 | San Diego, CA | ||
| 50M | 181 | New Haven, CT | 2017 | |
| 50M | 58 | Carlsbad, CA |